Last reviewed · How we verify
NCT05191693
Long-term Outcomes of Endoscopic Papillary Balloon Dilation for 8-12mm Bile Duct Stones: a Prospective Study
trial testing ERCP in Endoscopic Papillary Balloon Dilation in 72 participants. Completed in 29 August 2020.
29 August 2020
Quick facts
| Lead sponsor | Venizelio General Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 72 |
| Start date | 30 September 2018 |
| Primary completion | 29 August 2020 |
| Estimated completion | 29 August 2020 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- ERCP
Conditions studied
- Endoscopic Papillary Balloon Dilation — all drugs for Endoscopic Papillary Balloon Dilation →
- Bile Duct Stones — all drugs for Bile Duct Stones →
- Endoscopic Sphincterotomy — all drugs for Endoscopic Sphincterotomy →
- Stone Recurrence — all drugs for Stone Recurrence →
Sponsor
Venizelio General Hospital
Who can join
Eligibility, any sex, with Endoscopic Papillary Balloon Dilation or Bile Duct Stones. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators prospectively evaluated long-term outcomes of ELBPD+EST for CBD stones up to 8-12mm. EPBD+EST in patients with CBD stones up to 8-12mm appears to be associated with a very low (\<3%) rate of long-term stone recurrence. The efficacy of EPBD for 8-12mm stones warrants further exploration in randomized trials.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Endoscopic papillary large-balloon dilation with sphincterotomy for difficult common bile duct stones ≤12 mm: a prospective study.
Velegraki M, Arna D, Nikolaou P, Psistakis A, et al · · 2024 · cited 1× · PMID 38223243 · DOI 10.20524/aog.2023.0855
Verify or expand the search:
- PubMed search for NCT05191693
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ERCP
Trials testing the same drug.
- NCT07455227 — ERCP Management in Mild Gallstone-Induced Pancreatitis Patients Declining Subsequent Cholecystectomy : a Randomized Cont · NA · not yet recruiting
- NCT06900790 — Management of Pediatric Pancreatic Calculi At a Single Center: a Retrospective Cohort Study · not yet recruiting
- NCT06456476 — Patients With Obstructive Jaundice In Sohag University Hospital · recruiting
- NCT06363682 — Interventional Reference Levels (IRL) in Digestive Endoscopy · unknown
- NCT06197984 — Antimicrobial Resistance in Acute Cholangitis · recruiting
Other Venizelio General Hospital trials
Trials by the same sponsor.
- NCT04805567 — Adenoma Miss Rate in Tandem Endocuff-assisted Colonoscopy · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05191693 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Venizelio General Hospital
- Last refreshed: 13 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05191693.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing